Genmab A/S (GNMSF)
OTCMKTS · Delayed Price · Currency is USD
297.22
0.00 (0.00%)
Oct 22, 2025, 8:00 PM EDT
Genmab Market Cap
Genmab has a market cap or net worth of $18.32 billion as of October 24, 2025. Its market cap has increased by 22.78% in one year.
Market Cap
18.32B
Enterprise Value
15.59B
Revenue
3.65B
Ranking
n/a
PE Ratio
13.36
Stock Price
$297.22
Market Cap Chart
Since October 18, 2000, Genmab's market cap has increased from 415.12M to 18.32B, an increase of 4,312.26%. That is a compound annual growth rate of 16.33%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Oct 24, 2025 | 18.32B | 38.82% |
| Dec 30, 2024 | 13.19B | -36.79% |
| Dec 29, 2023 | 20.88B | -24.42% |
| Dec 30, 2022 | 27.62B | 5.40% |
| Dec 30, 2021 | 26.20B | -1.50% |
| Dec 30, 2020 | 26.60B | 83.75% |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Veradigm | 806.69M |
| Elite Pharmaceuticals | 670.91M |
| Glass House Brands | 619.92M |
| Northwest Biotherapeutics | 371.21M |
| Silence Therapeutics | 344.81M |
| Nika Pharmaceuticals | 335.28M |
| CytoDyn | 327.16M |
| American Oncology Network | 291.52M |